Group 1 - Basel Medical Group Ltd has resolved its prior deficiency regarding the Periodic Filing Rule as it has complied with the filing requirements set by Nasdaq [1] - The company filed its amended annual report on Form 20-F for the fiscal year 2025 with the SEC on March 13, 2026 [1] Group 2 - Basel Medical is a Singapore-based provider of various medical services including orthopedic and trauma services, sports medicine, and neurosurgical treatments [2] - The company has established strong relationships with corporations in industries such as construction, marine, and oil & gas, which supports its business model [2] - Basel Medical is well-positioned to capitalize on growth opportunities in the private healthcare sector in Singapore and Southeast Asia, driven by factors such as aging populations and increasing healthcare expenditure [2]

Company Overview - Basel Medical Group Ltd is a Singapore-based provider of orthopedic and trauma services, sports medicine, and neurosurgical treatments, with operations primarily in Singapore [3] - The company has established strong relationships with corporations in construction, marine, and oil & gas industries, which support its robust business model [3] - Basel Medical has over 20 years of experience in the orthopedic service sector and is well-positioned to capitalize on growth opportunities in the private healthcare industry in Singapore and Southeast Asia [3] Financial Performance - The company reaffirmed the strength of its underlying financial performance despite recent volatility in its share price [1][2] - Basel Medical's subsidiaries have secured new sizable contracts, particularly in the supply chain, indicating robust operational execution [2] - The management emphasizes that the recent decline in share price does not reflect the intrinsic value of the business or the solid progress made [2] Strategic Outlook - Basel Medical is on track with its acquisition growth strategy, aiming to enhance its market position [2] - The company is poised to benefit from trends such as aging populations, rising income levels, increasing private insurance coverage, and growing sports participation rates in the region [3] - Singapore's status as a premium healthcare destination in Asia further supports the company's strategic outlook [3]